- Oops!Something went wrong.Please try again later.
A Relative Strength Rating upgrade for Advanced Micro Devices shows improving technical performance.
What happened Shares of several COVID-19 vaccine makers were sliding on Monday. BioNTech stock (NASDAQ: BNTX) was down 6.5% at 12:09 p.m. EDT. Shares of Moderna (NASDAQ: MRNA) had slipped 4.4%. Novavax (NASDAQ: NVAX) stock had fallen 6%.
Ending the week on a sour note, shares of Bloom Energy (NYSE: BE), FuelCell Energy (NASDAQ: FCEL), and Plug Power (NASDAQ: PLUG) all tumbled lower on Friday. As of 11:48 a.m. EDT, shares of Bloom Energy are up 5.3%, while FuelCell Energy's stock and Plug Power's stock are up 10.2% and 6.1%, respectively. While some positive news from Wall Street is a catalyst for the rise in Plug Power's stock today, other investors are choosing to power up their portfolios with Bloom Energy and FuelCell Energy after learning of some encouraging news out of the Golden State.
Names in the electric vehicle sector sometimes move as a group, but three stocks that are doing their own thing today are Nio (NYSE: NIO), Nikola (NASDAQ: NKLA), and Canoo (NASDAQ: GOEV). As of 11:30 a.m. EDT, Nio shares were about 2% higher, while Nikola shares were up nearly 5%. Canoo's move makes sense.
A vote on the bipartisan infrastructure bill is scheduled for this Thursday in the House of Representatives.
Shares of Apple (NASDAQ: AAPL) stock dipped 1.5% in noonday trading, EDT, Monday, and the slip appears tied to some news out of Europe that broke late last week. As The Verge reported Thursday, the European Commission, the executive arm of the European Union, is considering mandating that all cellphones sold in the EU use a standard USB-C power cord. It could be a big problem for Apple, however, which uses, and sells, proprietary Lightning cables to charge its iPhones.
In this article, we reviewed Bridgewater Associates founder Ray Dalio’s portfolio adjustment strategies to cope up with the market volatility. We also discussed the top ten stocks billionaire Ray Dalio is buying. You can skip our detailed discussion and jump directly to Billionaire Ray Dalio is Buying These 5 Stocks. Raymond Thomas Dalio’s $223 billion […]
The Securities and Exchange Commission charged two traders with engaging in so-called "wash trading" of meme stocks, including GameStop, Inc. in alleged scheme that netted them hundreds of thousands of dollars in ill-gotten rebates from a number of stock brokers.
As GOOGL stock tests support and AMZN stock tests resistance, Microsoft rides work-at-home and cloud trends, lifting MSFT stock toward buy.
Citigroup analyst P.J. Juvekar visited Plug Power recently and came away impressed with its plans to expand its hydrogen-gas-making capabilities.
The Dow Jones rose. Nancy Pelosi made an infrastructure bill move. AMD stock offered a buy point. Tesla stock gained, Apple stock fell.
Sometimes an inheritance includes more than a house or an heirloom vase. Investors can choose to pass down to their heirs financial securities like stocks. Determining the value of such a bequest is vital. Without the proper calculations or procedures, … Continue reading → The post What Is the Cost Basis of Inherited Stock? appeared first on SmartAsset Blog.
Biotech stocks have been some of the most reliable capital-appreciation vehicles in the entire market for the past two decades. As proof, biotech equities such as CRISPR Therapeutics, Moderna, Novavax, Ocugen, and Vertex Pharmaceuticals -- just to name a few -- have all made their early shareholders market-crushing gains. Not all biotech stocks are cut from the same cloth, however.
Dell Technologies (NYSE: DELL) shareholders are about to realize a corporate event they've been looking forward to for over a year now: the tax-free spinoff of Dell's 80.6% stake in virtualization software company VMware (NYSE: VMW). Dell's stock has already done quite well in 2021, up more than 40% on the year, in anticipation of the move. Last week, management held an analyst day, touting its outlook for the core business, as well as the future implementation of a large share repurchase plan and initiation of what looks to be a hefty future dividend.
Investors love healthcare stocks in both bull markets and times of uncertainty, but not all investments are slam-dunks. The following three healthcare-related stocks have a handful of specific characteristics that make them great candidates to fulfill different roles in your investment portfolio. CVS Health (NYSE: CVS) is a diverse healthcare company that operates a chain of drugstores, a pharmacy benefits management business, and a major health insurance carrier since its 2017 acquisition of Aetna.
The United Nations anticipates that the global population over the age of 65 is expected to surge from 727 million people in 2020 to over 1.5 billion people by 2050. Long-term investors should consider purchasing Amgen (NASDAQ: AMGN). There are 20 molecules currently in phase 1 clinical trials and 19 molecules in phase 2 or 3 clinical trials.
Photo by Fredrick Tendong on Unsplash On Facebook’s Q2 2021 earnings call, CEO Mark Zuckerberg and others mentioned the metaverse 20 different times. Roblox mentioned the metaverse 16 times on its call and Unity Technologies did so 8 times. Why are leading social media and video game companies so enamored with this term? It’s because many expect the metaverse to emerge as the next evolution of the internet, presenting trillions of dollars of opportunities, as well as risks, to today’s leading pl
It sounds like you may need a third party — a financial adviser or financial therapist — to show you on paper that you can afford to live within your means for many years to come. Having a worthy financial goal will give you something solid to focus on, instead of a blank canvas of what could happen in the future.
The market's recent volatility may have you feeling skittish, but it has turned some good investing opportunities into even better deals.
STOCKSTOWATCHTODAY BLOG Tesla stock has been dead money for much of 2021—but it’s showing signs of life again. The next month could go a long way in determining the direction of the stock over the next couple of quarters and beyond.
Investors have been rewarding companies that are doing a particularly good job of pumping out free cash flow and increasing their shareholder returns.